Search

Your search keyword '"M. Moschini"' showing total 32 results

Search Constraints

Start Over You searched for: Author "M. Moschini" Remove constraint Author: "M. Moschini" Journal world journal of urology Remove constraint Journal: world journal of urology
32 results on '"M. Moschini"'

Search Results

1. The role of re-transurethral resection of bladder tumor in patients with TaHG non muscle invasive bladder cancer.

2. Prognostic significance of residual tumor at restaging transurethral bladder resection in high-risk non-muscle-invasive bladder cancer.

3. Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center.

4. Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.

5. Clinical value of cholinesterase in patients treated with radical nephroureterectomy for upper urinary tract carcinoma.

6. Impact of smoking on urologic cancers: a snapshot of current evidence.

7. Impact of sex on outcomes after surgery for non-muscle-invasive and muscle-invasive bladder urothelial carcinoma: a systematic review and meta-analysis.

8. Changes in renal function after nephroureterectomy for upper urinary tract carcinoma: analysis of a large multicenter cohort (Radical Nephroureterectomy Outcomes (RaNeO) Research Consortium).

9. The accuracy of Vesical Imaging-Reporting and Data System (VI-RADS): an updated comprehensive multi-institutional, multi-readers systematic review and meta-analysis from diagnostic evidence into future clinical recommendations.

10. Neoadjuvant chemotherapy does not increase peri-operative morbidity following radical cystectomy.

11. Carboplatin-based adjuvant chemotherapy versus observation after radical cystectomy in patients with pN1-3 urothelial bladder cancer.

12. Current application of the enhanced recovery after surgery protocol for patients undergoing radical cystectomy: lessons learned from European excellence centers.

13. Immediate radical cystectomy versus BCG immunotherapy for T1 high-grade non-muscle-invasive squamous bladder cancer: an international multi-centre collaboration.

14. Prognostic value of the systemic immune-inflammation index in non-muscle invasive bladder cancer.

15. Delaying BCG immunotherapy onset after transurethral resection of non-muscle-invasive bladder cancer is associated with adverse survival outcomes.

16. Adjuvant chemotherapy is ineffective in patients with bladder cancer and variant histology treated with radical cystectomy with curative intent.

17. The impact of preoperative nutritional status on post-surgical complication and mortality rates in patients undergoing radical cystectomy for bladder cancer: a systematic review of the literature.

18. The impact of treatment modality on survival in patients with clinical node-positive bladder cancer: results from a multicenter collaboration.

19. Trends in risk-group distribution and Pentafecta outcomes in patients treated with nerve-sparing, robot-assisted radical prostatectomy: a 10-year low-intermediate volume single-center experience.

20. Expression of urokinase-type plasminogen activator system in non-metastatic prostate cancer.

21. How to improve patient selection for neoadjuvant chemotherapy in bladder cancer patients candidate for radical cystectomy and pelvic lymph node dissection.

22. The impact of completeness of last transurethral resection of bladder tumors on the outcomes of radical cystectomy.

23. The effect of androgen deprivation treatment on subsequent risk of bladder cancer diagnosis in male patients treated for prostate cancer.

24. Contemporary rates of adherence to international guidelines for pelvic lymph node dissection in radical cystectomy: a population-based study.

25. Surgical treatment for clinical node-positive bladder cancer patients treated with radical cystectomy without neoadjuvant chemotherapy.

26. Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.

27. Trends of lymphadenectomy in upper tract urothelial carcinoma (UTUC) patients treated with radical nephroureterectomy.

28. Prognostic role of expression of N-cadherin in patients with upper tract urothelial carcinoma: a multi-institutional study.

29. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

30. HER2 overexpression is associated with worse outcomes in patients with upper tract urothelial carcinoma (UTUC).

31. A nomogram predicting the cancer-specific mortality in patients eligible for radical cystectomy evaluating clinical data and neoadjuvant cisplatinum-based chemotherapy.

32. Fifteen-year single-centre experience with three different surgical procedures of nerve-sparing cystectomy in selected organ-confined bladder cancer patients.

Catalog

Books, media, physical & digital resources